IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label due diligence. Show all posts

Showing posts with label due diligence. Show all posts

Thursday, 3 September 2015

Reducing risks in VC investments Part II: investing in software

Here's the second part of a two-part feature on venture capital, risk and investment, by Martin Callinan (Source Code Control) and Kat...

Wednesday, 2 September 2015

Reducing risks in VC investments Part I: risk and due diligence

If only ... Here's the first part of a two-part feature on venture capital, risk and investment, by Martin Callinan (Source Code Con...

Thursday, 4 December 2014

IP Issues in Mergers and Acquisitions: Any Recent Examples of Due Diligence Failures Involving IP?

Corporate Counsel has published a pair of informative articles concerning due diligence and intellectual property. The first article i...

Friday, 12 September 2014

When clinical trial data is fudged; woe to the company or woe to the industry?

When I think of clinical test data, my attention is usually drawn to controversial Article 39.3 of the TRIPS Agreement, which affords prot...

View web version

Powered by Blogger.